Showing results (21-30 of 199) with videos related to
Sort By:
Pageof 20
Microbes and Infection|November 14, 2003
Neutrophil granules and secretory vesicles in inflammationMikkel Faurschou, Niels BorregaardDanish Medical Bulletin|November 3, 2010
Evidence-based recommendations for treatment with methotrexate in rheumatic disordersOle Rintek Madsen, Mikkel Faurschou, Anne Gitte Loft, et al.Ugeskrift for Laeger|June 21, 2008
[Biological treatment of rare inflammatory rheumatic diseases]Bo BaslundAnnual Review of Medicine|October 29, 2013
Anti-B cell antibody therapies for inflammatory rheumatic diseasesMikkel Faurschou, David R W JayneThe Journal of Rheumatology|November 1, 2025
Comorbidity Development and Mortality During 10 Years of Follow-up in Danish Nationwide Cohort of 3,178 Patients with Systemic Lupus ErythematosusRenata Baronaite Hansen, Mikkel Faurschou, Søren JacobsenUgeskrift for Laeger|June 25, 2008
[Biopharmaceuticals in the treatment of rheumatoid arthritis]Bo Baslund, Klaus BendtzenThe Journal of Rheumatology|August 2, 2006
Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failureMikkel Faurschou, Henrik Starklint, Poul Halberg, et al.The Journal of Rheumatology|November 16, 2021
Long-term Risk of Heart Failure and Other Adverse Cardiovascular Outcomes in Granulomatosis With Polyangiitis: A Nationwide Cohort StudyGuoli Sun, Adelina Yafasova, Bo Baslund, et al.Best Practice & Research. Clinical Rheumatology|March 20, 2013
ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationshipsAlfred Mahr, Caroline Heijl, Guillaume Le Guenno, et al.Journal of the American College of Cardiology|April 9, 2021
Long-Term Cardiovascular Outcomes in Systemic Lupus ErythematosusAdelina Yafasova, Emil L Fosbøl, Morten Schou, et al.Pageof 20